Statistics

Total Visits

Views
Randomized, phase II trial comparing continuous versus intermittent capecitabine (X) monotherapy for metastatic breast cancer (MBC): Results from the GEICAM 2009-05 study52

Select a period of time:

Number of views in the range

Views
Randomized, phase II trial comparing continuous versus intermittent capecitabine (X) monotherapy for metastatic breast cancer (MBC): Results from the GEICAM 2009-05 study17

Views

Views
June 20250
July 202515
August 20250
September 20251
October 20250
November 20250
December 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil9
United States4
Argentina1
Barbados1
Peru1
Turkey1
 

Top cities views

Views
Rio de Janeiro3
Belo Horizonte1
Cordova1
La Grange1
Lima1
Miguelópolis1
Mococa1
Paripiranga1
Rockford1
Saint Michael1